Nuvox Therapeutics
Business Services · Arizona, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6363 N Swan Rd Ste 151, Tucson, Arizona,...Website
www.nuvoxtherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Nuvox Therapeutics
Nuvox Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvox Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Nuvox Therapeutics had a recent Job posting/layoffs
Check out if Nuvox Therapeutics is spiking on competitors!
Earning: See what the market has to say on Nuvox Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nuvox Therapeutics
Funding: Get notified immidiatlly once Nuvox Therapeutics has new funding data
Nuvox Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Nuvox Therapeutics launches new products
Check if Nuvox Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Nuvox Therapeutics as Masked Content
Find 2 more new buyers
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nuvox Therapeutics
NuvOx Therapeutics is a clinical-stage biopharmaceutical company developing NanO2, an oxygen therapeutic for hypoxia-driven diseases. Administered intravenously, NanO2's nano-sized dodecafluoropentane droplets deliver oxygen to tissue. Focus areas include acute ischemic stroke, glioblastoma (GBM), and ARDS, with Phase IIb trials ongoing. FDA grante... Read More
